400 MG Daratumumab Concentrate For Solution For Infusion
400 MG Daratumumab Concentrate For Solution For Infusion

400 MG Daratumumab Concentrate For Solution For Infusion

Price 45000 INR/ Vial

MOQ : 100 Vials

400 MG Daratumumab Concentrate For Solution For Infusion Specification

  • Salt Composition
  • Daratumumab 400 mg
  • Indication
  • Multiple myeloma (treatment of adult patients with multiple myeloma)
  • Dosage Form
  • Concentrate For Solution For Infusion
  • Enzyme Types
  • Not applicable (Monoclonal antibody, not an enzyme)
  • Feature
  • Other
  • Ingredients
  • Other
  • Application
  • Other
  • Ph Level
  • Approximately 5.5 to 6.0
  • Physical Color/Texture
  • Clear to opalescent, colorless to slightly yellow solution
  • Storage Instructions
  • Store at 2C to 8C (Refrigerate, Do not freeze)
  • Shelf Life
  • 24 months (unopened vial under recommended conditions) Months
  • Contraindications
  • Hypersensitivity to daratumumab or any ingredient in formulation
  • Precautions
  • Monitor for infusion-related reactions; pre-medication recommended
  • Packaging
  • Single vial of 20 mL
  • Infusion Time
  • Initial infusion (first administration): approximately 7 hours; subsequent infusions: shorter duration as tolerated
  • Route of Administration
  • Intravenous infusion only
  • Prescription Status
  • Prescription-only medicine
  • Strength
  • 400 mg/20 mL (20 mg/mL)
  • Compatibility
  • Compatible with PVC and polyolefin infusion bags
  • Diluent Required
  • Must be diluted with 0.9% Sodium Chloride Injection prior to infusion
 

400 MG Daratumumab Concentrate For Solution For Infusion Trade Information

  • Minimum Order Quantity
  • 100 Vials
  • Payment Terms
  • Cash in Advance (CID)
  • Supply Ability
  • 5000 Vials Per Month
  • Delivery Time
  • 10 Days
  • Main Domestic Market
  • All India
 

About 400 MG Daratumumab Concentrate For Solution For Infusion



Highlighted as an illustrious choice in oncology, 400 MG Daratumumab Concentrate For Solution For Infusion stands out for adult patients with multiple myeloma. Delivered via intravenous infusion, this single-use, preservative-free vial offers unbeatable purity and stability. Select medical centers across India have remarked on its consistent efficacy and manageable administration timeframes. The product must be diluted with 0.9% sodium chloride before use and displays compatibility with both PVC and polyolefin bags. Savings in storage efficiency and reliability underscore its remarkable position among similar therapies. Prescription-only.

Daratumumab 400mg: Diverse Applications for Multiple Myeloma

This 400 MG Daratumumab solution is specifically developed for use in treating adult patients with multiple myeloma. The product finds its application in hematology clinics, specialized oncology centers, and tertiary care hospitals. Used exclusively for intravenous infusions after dilution, it is suited for initial lengthy infusions, as well as shorter repeat administrations as patients tolerate. Its compatibility, stability, and trusted formulation make it a vital addition for practitioners managing multiple myeloma cases.


Efficient Procurement: Payment, Delivery & Sample Logistics

Flexible payment terms accommodate the needs of various healthcare facilities and traders. Our logistics ensure quick dispatch and dependable delivery, with express shipping available on request to guarantee timely arrivals. Each order is handled with meticulous care across India, and sample vials can be arranged for evaluation. You can rely on streamlined processes and robust logistics to support your procurement needs, ensuring seamless delivery of this essential oncology medication.


FAQ's of 400 MG Daratumumab Concentrate For Solution For Infusion:


Q: How should 400 MG Daratumumab Concentrate be administered?

A: Daratumumab is administered via intravenous infusion only, after dilution with 0.9% sodium chloride. The initial infusion takes approximately 7 hours, with shorter durations for subsequent infusions as tolerated.

Q: What advantages does Daratumumab offer for multiple myeloma patients?

A: Daratumumab is a monoclonal antibody highlighted for its effectiveness in treating adult patients with multiple myeloma, offering improved response rates and overall management in combination with established therapies.

Q: Where should the concentrate be stored to maintain its quality?

A: The unopened vial should be stored refrigerated at 2C to 8C. It must not be frozen and should be kept within its shelf life of 24 months for optimal potency.

Q: What is the process for ordering Daratumumab from India?

A: To place an order, contact us directly to discuss payment terms and shipment options. We provide quick dispatch and express shipping for both bulk and smaller quantities, with sample vials available if required.

Q: When is pre-medication recommended during treatment?

A: Pre-medication is advised before each infusion to minimize the risk of infusion-related reactions, which are a known complication during daratumumab therapy.

Q: Is this product compatible with standard infusion equipment?

A: Yes, Daratumumab concentrate is compatible with both PVC and polyolefin infusion bags, making it versatile for use in most hematology and oncology settings.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti-Cancer Medicine Category

395 MG Pembrolizumab And Berahyaluronidase Alfa Injection

395 MG Pembrolizumab And Berahyaluronidase Alfa Injection

Minimum Order Quantity : 100 Packs

Dosage Form : Injection

Ingredients : Other , Pembrolizumab, Berahyaluronidase alfa, excipients, sterile water for injection

Feature : Other, Prefilled syringe, readytouse, enhances monoclonal antibody absorption

Physical Color/Texture : Other , Clear to slightly opalescent, colorless to pale yellow solution

Indication : Treatment of certain cancers including melanoma, nonsmall cell lung cancer, and others as determined by a healthcare professional

2 MG Aflibercept Injection

2 MG Aflibercept Injection

Minimum Order Quantity : 100 Packs

Dosage Form : Injection

Ingredients : Other , Aflibercept, buffers, stabilizers, water for injection

Feature : Other, Sterile, readytouse, preservativefree, singleuse vial

Physical Color/Texture : Other , Colorless to pale yellow, clear, aqueous solution

Indication : Treatment of neovascular (wet) agerelated macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, and diabetic retinopathy

Nivolumab Injection

Nivolumab Injection

Minimum Order Quantity : 100 Vials

Dosage Form : Injection

Ingredients : Other

Feature : Other

Physical Color/Texture : Other , Clear to slightly opalescent, colorless to pale yellow solution

Indication : Treatment of advanced melanoma, nonsmall cell lung cancer, renal cell carcinoma, classical Hodgkin lymphoma, squamous cell carcinoma of the head and neck, urothelial carcinoma and other cancers.

Cyclophosphamide For Injection USP

Cyclophosphamide For Injection USP

Minimum Order Quantity : 100 Packs

Dosage Form : Injection

Ingredients : Other , Cyclophosphamide monohydrate

Feature : Other, Sterile, pyrogenfree, lyophilized powder

Physical Color/Texture : Other , White crystalline powder

Indication : Malignant disease, immunosuppressive therapy



Back to top